Log In
Print
BCIQ
Print
Print this Print this
 

CK-2127107

  Manage Alerts
Collapse Summary General Information
Company Cytokinetics Inc.
DescriptionFast skeletal muscle troponin activator
Molecular Target Sarcomere
Mechanism of ActionSarcomere activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMuscular atrophy
Indication DetailsTreat neuromuscular dysfunction, muscular weakness and muscle fatigue; Treat sarcopenia and general frailty
Regulatory Designation

Partner

Astellas Pharma Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today